Vivos therapeutics and candid announce strategic collaboration to deliver a comprehensive sleep apnea and orthodontic treatment solution

Highlands ranch, colo., oct. 19, 2021 /prnewswire/ -- vivos therapeutics, inc. ("vivos" or "the company") (nasdaq: vvos), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (osa) and snoring, and  candid care co. ("candid") , a digital platform for oral healthcare, today announced a new collaboration that will seek to provide patients with a comprehensive, whole-mouth solution to diagnose and treat osa in adult patients and provide orthodontic treatment from the same provider network.
VVOS Ratings Summary
VVOS Quant Ranking